CMC Pharmaceuticals, Inc.

CMC Pharmaceuticals operates as a contract development and manufacturing partner specializing in Chemistry, Manufacturing, and Controls (CMC) services for small molecule pharmaceuticals. The company offers end-to-end drug development support spanning formulation optimization, analytical method development and validation, ICH stability and compatibility studies, scale-up and technology transfer, and cGMP manufacturing oversight.

Service Capabilities:

• Formulation development and process optimization across traditional and novel dosage forms
• Analytical development, method validation, and release testing
• ICH stability evaluations and shelf-life extension studies
• Small-scale non-GMP production (pilot plant for preclinical batches)
• Scale-up, technology transfer, and CMO qualification and management
• Regulatory support including IND/NDA preparation, FDA information request responses, and post-approval CMC support
• Expertise in controlled substances and highly potent compounds
• cGMP laboratory services and quality assurance/compliance oversight

Differentiation: Unlike traditional CDMOs, CMC Pharma emphasizes flexibility and early-stage program support, avoiding lock-in to specific technologies or dosage forms. The company operates an integrated model combining lab capabilities, regulatory expertise, and CMO oversight to minimize handoffs and reduce development risk. Over 95% of sales orders come from repeat clients, reflecting long-term partnerships built on transparent pricing, on-time delivery, and confidentiality.